isoxazoles has been researched along with Angiitis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiemstra, TF; Jayne, D | 1 |
| Karjalainen, A; Pettersson, T | 1 |
| Cunnane, G; Daikh, DI; Fye, KH; Warnock, M | 1 |
| Bradlow, A; Chan, AT; McNally, J | 1 |
| Bruyn, GA | 1 |
| Gan, BS; Harth, M; Lazarescu, A; Macdonald, J; Zhong, T | 1 |
| Dissemond, J; Goos, M; Knab, J | 1 |
| de Groot, K; Jayne, D | 1 |
| Bentaberry, F; Dehais, J; Dumoulin, C; Haramburu, F; Martin, K; Miremont-Salamé, G; Schaeverbeke, T | 1 |
| Bijlsma, JW; Geenen, R; Goldschmeding, R; Kruize, AA; van Roon, EN; van Roon, JA; van Woerkom, JM; Verstappen, SM | 1 |
| Parker, LC; Sabroe, I; Ward, JR; West, PW | 1 |
| Gross, WL | 1 |
| Kallenberg, CG; Stegeman, CA; Tervaert, JW | 1 |
5 review(s) available for isoxazoles and Angiitis
| Article | Year |
|---|---|
Newer therapies for vasculitis.
Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Plasma Exchange; Stem Cell Transplantation; Treatment Outcome; Vasculitis | 2009 |
[Diagnosis and management of small vessel vasculitides].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Progression; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Vasculitis | 2010 |
What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisolone; Receptors, Tumor Necrosis Factor; Vasculitis | 2005 |
New concepts in treatment protocols for severe systemic vasculitis.
Topics: Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Vasculitis | 1999 |
Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antilymphocyte Serum; Cyclophosphamide; Guanidines; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Isoxazoles; Kidney Diseases; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisone; Remission Induction; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha; Vasculitis | 2001 |
1 trial(s) available for isoxazoles and Angiitis
| Article | Year |
|---|---|
Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study.
Topics: Adult; Aniline Compounds; Crotonates; Diarrhea; Facial Dermatoses; Fatigue; Female; Humans; Hydroxybutyrates; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Middle Aged; Nitriles; Pilot Projects; Sjogren's Syndrome; Statistics, Nonparametric; Toluidines; Vasculitis | 2007 |
7 other study(ies) available for isoxazoles and Angiitis
| Article | Year |
|---|---|
Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Radiography, Thoracic; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatoid Nodule; Tomography, X-Ray Computed; Treatment Outcome; Vasculitis | 2002 |
Leflunomide induced vasculitis--a dose-response relationship.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Skin Diseases, Vascular; Vasculitis | 2003 |
Extraarticular rheumatoid arthritis and drug-induced syndromes: understanding the role of tumor necrosis factor inhibitors.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Infliximab; Isoxazoles; Leflunomide; Tumor Necrosis Factor-alpha; Vasculitis | 2004 |
Vasculitis associated with the use of leflunomide.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Treatment Outcome; Vasculitis | 2004 |
Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy.
Topics: Aged; Arthritis, Rheumatoid; Cholestyramine Resin; Debridement; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leg Ulcer; Skin Transplantation; Vasculitis; Wound Healing | 2005 |
Peripheral neuropathy associated with leflunomide: is there a risk patient profile?
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Complications; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Neurologic Examination; Peripheral Nervous System Diseases; Rheumatoid Factor; Risk Assessment; Vasculitis | 2007 |
Differential and cell-type specific regulation of responses to Toll-like receptor agonists by ISO-1.
Topics: Cells, Cultured; Coculture Techniques; Cytokines; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Humans; Interleukin-8; Isoxazoles; Lipopolysaccharides; Macrophage Migration-Inhibitory Factors; Macrophages; Monocytes; Signal Transduction; Toll-Like Receptor 4; Toll-Like Receptors; Vasculitis | 2008 |